Selected research
Market Analysis & Forecast
Global Nanopore Long-Reads Sequencing Market Analysis and Forecast 2026-2032
Market perspective
The global Nanopore Long-Reads Sequencing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Nanopore Long-Reads Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Nanopore Long-Reads Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Nanopore Long-Reads Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Nanopore Long-Reads Sequencing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Nanopore Long-Reads Sequencing include Pacific Biosciences of California, Inc., Oxford Nanopore Technologies Limited, Thermo Fisher, Roche, 10X Genomics, Eurofins Genomics, Stratos Genomics, Inc., MicrobesNG and NextOmics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Nanopore Long-Reads Sequencing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Nanopore Long-Reads Sequencing, also provides the revenue of main regions and countries. Of the upcoming market potential for Nanopore Long-Reads Sequencing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nanopore Long-Reads Sequencing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nanopore Long-Reads Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Nanopore Long-Reads Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Nanopore Long-Reads Sequencing Segment by Company
Pacific Biosciences of California, Inc.
Oxford Nanopore Technologies Limited
Thermo Fisher
Roche
10X Genomics
Eurofins Genomics
Stratos Genomics, Inc.
MicrobesNG
NextOmics
New England Biolabs
Pacbio
Illumina
Stratos Genomics
Nanopore Long-Reads Sequencing Segment by Type
Pre-sequencing
Sequencing
Data Analysis
Nanopore Long-Reads Sequencing Segment by Application
Medical
Non-medical
Nanopore Long-Reads Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanopore Long-Reads Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanopore Long-Reads Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanopore Long-Reads Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Nanopore Long-Reads Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Nanopore Long-Reads Sequencing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nanopore Long-Reads Sequencing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pre-sequencing
- Sequencing
- Data Analysis
Applications
- Medical
- Non-medical
Companies covered
- Pacific Biosciences of California, Inc.
- Oxford Nanopore Technologies Limited
- Thermo Fisher
- Roche
- 10X Genomics
- Eurofins Genomics
- Stratos Genomics, Inc.
- MicrobesNG
- NextOmics
- New England Biolabs
- Pacbio
- Illumina
- Stratos Genomics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Nanopore Long-Reads Sequencing Market by Type
- 1.2.1 Global Nanopore Long-Reads Sequencing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Pre-sequencing
- 1.2.3 Sequencing
- 1.2.4 Data Analysis
- 1.3 Nanopore Long-Reads Sequencing Market by Application
- 1.3.1 Global Nanopore Long-Reads Sequencing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical
- 1.3.3 Non-medical
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Nanopore Long-Reads Sequencing Market Dynamics
- 2.1 Nanopore Long-Reads Sequencing Industry Trends
- 2.2 Nanopore Long-Reads Sequencing Industry Drivers
- 2.3 Nanopore Long-Reads Sequencing Industry Opportunities and Challenges
- 2.4 Nanopore Long-Reads Sequencing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Nanopore Long-Reads Sequencing Market Perspective (2021-2032)
- 3.2 Global Nanopore Long-Reads Sequencing Growth Trends by Region
- 3.2.1 Global Nanopore Long-Reads Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Nanopore Long-Reads Sequencing Market Size by Region (2021-2026)
- 3.2.3 Global Nanopore Long-Reads Sequencing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Nanopore Long-Reads Sequencing Revenue by Players
- 4.1.1 Global Nanopore Long-Reads Sequencing Revenue by Players (2021-2026)
- 4.1.2 Global Nanopore Long-Reads Sequencing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Nanopore Long-Reads Sequencing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Nanopore Long-Reads Sequencing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Nanopore Long-Reads Sequencing Key Players Headquarters & Area Served
- 4.4 Global Nanopore Long-Reads Sequencing Players, Product Type & Application
- 4.5 Global Nanopore Long-Reads Sequencing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Nanopore Long-Reads Sequencing Market CR5 and HHI
- 4.6.3 2025 Nanopore Long-Reads Sequencing Tier 1, Tier 2, and Tier 3
5 Nanopore Long-Reads Sequencing Market Size by Type
- 5.1 Global Nanopore Long-Reads Sequencing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
- 5.3 Global Nanopore Long-Reads Sequencing Revenue Market Share by Type (2021-2032)
6 Nanopore Long-Reads Sequencing Market Size by Application
- 6.1 Global Nanopore Long-Reads Sequencing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
- 6.3 Global Nanopore Long-Reads Sequencing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Pacific Biosciences of California, Inc.
- 7.1.1 Pacific Biosciences of California, Inc. Company Information
- 7.1.2 Pacific Biosciences of California, Inc. Business Overview
- 7.1.3 Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.1.4 Pacific Biosciences of California, Inc. Nanopore Long-Reads Sequencing Product Portfolio
- 7.1.5 Pacific Biosciences of California, Inc. Recent Developments
- 7.2 Oxford Nanopore Technologies Limited
- 7.2.1 Oxford Nanopore Technologies Limited Company Information
- 7.2.2 Oxford Nanopore Technologies Limited Business Overview
- 7.2.3 Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.2.4 Oxford Nanopore Technologies Limited Nanopore Long-Reads Sequencing Product Portfolio
- 7.2.5 Oxford Nanopore Technologies Limited Recent Developments
- 7.3 Thermo Fisher
- 7.3.1 Thermo Fisher Company Information
- 7.3.2 Thermo Fisher Business Overview
- 7.3.3 Thermo Fisher Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.3.4 Thermo Fisher Nanopore Long-Reads Sequencing Product Portfolio
- 7.3.5 Thermo Fisher Recent Developments
- 7.4 Roche
- 7.4.1 Roche Company Information
- 7.4.2 Roche Business Overview
- 7.4.3 Roche Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.4.4 Roche Nanopore Long-Reads Sequencing Product Portfolio
- 7.4.5 Roche Recent Developments
- 7.5 10X Genomics
- 7.5.1 10X Genomics Company Information
- 7.5.2 10X Genomics Business Overview
- 7.5.3 10X Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.5.4 10X Genomics Nanopore Long-Reads Sequencing Product Portfolio
- 7.5.5 10X Genomics Recent Developments
- 7.6 Eurofins Genomics
- 7.6.1 Eurofins Genomics Company Information
- 7.6.2 Eurofins Genomics Business Overview
- 7.6.3 Eurofins Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.6.4 Eurofins Genomics Nanopore Long-Reads Sequencing Product Portfolio
- 7.6.5 Eurofins Genomics Recent Developments
- 7.7 Stratos Genomics, Inc.
- 7.7.1 Stratos Genomics, Inc. Company Information
- 7.7.2 Stratos Genomics, Inc. Business Overview
- 7.7.3 Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.7.4 Stratos Genomics, Inc. Nanopore Long-Reads Sequencing Product Portfolio
- 7.7.5 Stratos Genomics, Inc. Recent Developments
- 7.8 MicrobesNG
- 7.8.1 MicrobesNG Company Information
- 7.8.2 MicrobesNG Business Overview
- 7.8.3 MicrobesNG Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.8.4 MicrobesNG Nanopore Long-Reads Sequencing Product Portfolio
- 7.8.5 MicrobesNG Recent Developments
- 7.9 NextOmics
- 7.9.1 NextOmics Company Information
- 7.9.2 NextOmics Business Overview
- 7.9.3 NextOmics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.9.4 NextOmics Nanopore Long-Reads Sequencing Product Portfolio
- 7.9.5 NextOmics Recent Developments
- 7.10 New England Biolabs
- 7.10.1 New England Biolabs Company Information
- 7.10.2 New England Biolabs Business Overview
- 7.10.3 New England Biolabs Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.10.4 New England Biolabs Nanopore Long-Reads Sequencing Product Portfolio
- 7.10.5 New England Biolabs Recent Developments
- 7.11 Pacbio
- 7.11.1 Pacbio Company Information
- 7.11.2 Pacbio Business Overview
- 7.11.3 Pacbio Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.11.4 Pacbio Nanopore Long-Reads Sequencing Product Portfolio
- 7.11.5 Pacbio Recent Developments
- 7.12 Illumina
- 7.12.1 Illumina Company Information
- 7.12.2 Illumina Business Overview
- 7.12.3 Illumina Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.12.4 Illumina Nanopore Long-Reads Sequencing Product Portfolio
- 7.12.5 Illumina Recent Developments
- 7.13 Stratos Genomics
- 7.13.1 Stratos Genomics Company Information
- 7.13.2 Stratos Genomics Business Overview
- 7.13.3 Stratos Genomics Nanopore Long-Reads Sequencing Revenue and Gross Margin (2021-2026)
- 7.13.4 Stratos Genomics Nanopore Long-Reads Sequencing Product Portfolio
- 7.13.5 Stratos Genomics Recent Developments
8 North America
- 8.1 North America Nanopore Long-Reads Sequencing Revenue (2021-2032)
- 8.2 North America Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
- 8.2.1 North America Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
- 8.2.2 North America Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
- 8.3 North America Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
- 8.4 North America Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
- 8.4.1 North America Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
- 8.4.2 North America Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
- 8.5 North America Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
- 8.6 North America Nanopore Long-Reads Sequencing Revenue by Country
- 8.6.1 North America Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Nanopore Long-Reads Sequencing Revenue by Country (2021-2026)
- 8.6.3 North America Nanopore Long-Reads Sequencing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Nanopore Long-Reads Sequencing Revenue (2021-2032)
- 9.2 Europe Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
- 9.2.1 Europe Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
- 9.2.2 Europe Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
- 9.3 Europe Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
- 9.4 Europe Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
- 9.4.1 Europe Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
- 9.4.2 Europe Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
- 9.5 Europe Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
- 9.6 Europe Nanopore Long-Reads Sequencing Revenue by Country
- 9.6.1 Europe Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Nanopore Long-Reads Sequencing Revenue by Country (2021-2026)
- 9.6.3 Europe Nanopore Long-Reads Sequencing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Nanopore Long-Reads Sequencing Revenue (2021-2032)
- 10.2 China Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
- 10.2.1 China Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
- 10.2.2 China Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
- 10.3 China Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
- 10.4 China Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
- 10.4.1 China Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
- 10.4.2 China Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
- 10.5 China Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Nanopore Long-Reads Sequencing Revenue (2021-2032)
- 11.2 Asia Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
- 11.2.1 Asia Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
- 11.2.2 Asia Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
- 11.3 Asia Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
- 11.4 Asia Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
- 11.4.1 Asia Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
- 11.4.2 Asia Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
- 11.5 Asia Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
- 11.6 Asia Nanopore Long-Reads Sequencing Revenue by Country
- 11.6.1 Asia Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Nanopore Long-Reads Sequencing Revenue by Country (2021-2026)
- 11.6.3 Asia Nanopore Long-Reads Sequencing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Nanopore Long-Reads Sequencing Revenue (2021-2032)
- 12.2 SAMEA Nanopore Long-Reads Sequencing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Nanopore Long-Reads Sequencing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Nanopore Long-Reads Sequencing Revenue by Type (2027-2032)
- 12.3 SAMEA Nanopore Long-Reads Sequencing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Nanopore Long-Reads Sequencing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Nanopore Long-Reads Sequencing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Nanopore Long-Reads Sequencing Revenue by Application (2027-2032)
- 12.5 SAMEA Nanopore Long-Reads Sequencing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Nanopore Long-Reads Sequencing Revenue by Country
- 12.6.1 SAMEA Nanopore Long-Reads Sequencing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Nanopore Long-Reads Sequencing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Nanopore Long-Reads Sequencing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst